MAPK1 and esophageal squamous cell carcinoma: In esophageal squamous cell carcinoma (ESCC), the effect of 5-fluorouracil was completely different: in this case, the chemotherapeutic agent induced activation of Erk and Akt in ESCC cells, both in vivo and in vitro.